PAEDIATRIC PSORIASIS: A REVIEW ON DIAGNOSIS AND MANAGEMENT

REVIEW ARTICLE - PHARMACY, DERMATOLOGY

Psoriasis is a most common skin disease with genetic underpinnings.1 Psoriasis is an itchy dry white scaly patches on the skin. About 40% of psoriatic patients have an age of onset before 16 years and 10% of them get it before their 10 years of life. Paediatric psoriasis may vary from mild moderate to severe, even though it’s a lifelong condition without cure, symptomatic treatment with medications are available. Most of the paediatric cases are mild and get better with treatment. Treatment for paediatric psoriasis has no internationally standardised guidelines. It may include topical therapy, systemic therapy and phototherapy. while selecting a specific treatment factors such as age, quality of life, severity of psoriasis, location of psoriasis, type of psoriasis, tolerability, safety and patient preference is to be considered. topicals includes calcineurins, vitamin d analogues alone and in combination with topical corticosteroids. The disease can get controlled with intermittent therapy in most of the patients; but in some it get worsen with age and may require aggressive therapy. New innovations in the systemic, topical, phototherapy and biologic may provide a better future in paediatric psoriasis therapeutic armantarium.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.